Back to Journals
Biosimilars ceased publishing in October 2016. All new submissions can be made to Biologics: Targets and Therapy. All articles that have been published in Biosimilars will continue to be available on the Dove Press site, and will be securely archived with CLOCKSS.
An international, peer reviewed, open access journal focusing on the manufacture, development, and medicinal use of biopharmaceutical compounds considered similar to an innovator agent.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).